Dermatologicals in Uzbekistan
Retail sales of dermatologicals showed moderate growth in current value terms in 2022, mainly as a result of inflationary pressures. Dermatologicals suffered from stagnation in 2020, as consumers spent more time at home and were therefore less exposed to environments which could lead to skin conditions. With a return to pre-pandemic lifestyles, several products saw a rebound in demand in 2022, with topical allergy remedies/antihistamines leading the way, despite the growing popularity of systemi...
Euromonitor International's Dermatologicals in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Dermatologicals in Uzbekistan
- Euromonitor International
- October 2022
- List Of Contents And Tables
- DERMATOLOGICALS IN UZBEKISTAN
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Certain treatments see a rebound in 2022, but sales remain underdeveloped
- Paediatric dermatologicals see varying levels of demand
- Global players lead sales, but domestic players still play a key role amongst price conscious consumers
- PROSPECTS AND OPPORTUNITIES
- Future development of dermatologicals will depend on the Uzbekistan economy
- Products deemed as essential will support ongoing growth
- Global brands to remain dominant
- CATEGORY DATA
- Table 1 Sales of Dermatologicals by Category: Value 2017-2022
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
- Table 5 Forecast Sales of Dermatologicals by Category: Value 2022-2027
- Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN UZBEKISTAN
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventative medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook